After a dwindle in the number of reclassifications of prescription-only to pharmacy medicines in the UK, things are starting to look up, writes Natalie Gauld.
Limiting HIV resistance must not be neglected in an era where we continue to see breakthroughs in treatment for the infection once labelled a death sentence.
Cholesterol-lowering statin therapy for healthy people is not as simple as 'yes' or 'no'Subscription
Recent reports of large trials extolling the virtues of statins have led many to believe that low-risk patients should take them, but an examination of the evidence provides food for thought.
There are a number of factors that contribute to patients’ fear and reluctance to take osteoporosis drugs, leaving them at increased risk of fractures.
Research suggests no substantive outcome differences between the use of originator biologics and their biosimilar counterparts Source: Shutterstock.com